Teleflex Incorporated (NYSE:TFX - Get Free Report) has been given a consensus recommendation of "Hold" by the twelve analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $151.80.
A number of analysts have recently commented on TFX shares. Royal Bank Of Canada raised shares of Teleflex from a "sector perform" rating to an "outperform" rating and boosted their price objective for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Piper Sandler reaffirmed an "overweight" rating and issued a $169.00 target price (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. Weiss Ratings reiterated a "sell (d)" rating on shares of Teleflex in a research note on Wednesday, June 24th. Zacks Research raised shares of Teleflex from a "strong sell" rating to a "hold" rating in a research report on Tuesday, April 28th. Finally, Wells Fargo & Company boosted their price target on shares of Teleflex from $130.00 to $138.00 and gave the stock an "equal weight" rating in a research report on Friday, May 8th.
Check Out Our Latest Stock Analysis on TFX
Institutional Trading of Teleflex
Several institutional investors and hedge funds have recently bought and sold shares of TFX. Kelleher Financial Advisors acquired a new position in shares of Teleflex during the 2nd quarter worth approximately $25,000. Banque Cantonale Vaudoise boosted its holdings in shares of Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company's stock valued at $31,000 after buying an additional 113 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company's stock valued at $38,000 after buying an additional 113 shares in the last quarter. Allworth Financial LP bought a new position in shares of Teleflex in the second quarter valued at $44,000. Finally, Kestra Advisory Services LLC acquired a new position in Teleflex during the fourth quarter worth $45,000. Institutional investors own 95.62% of the company's stock.
Teleflex Stock Down 0.1%
NYSE:TFX opened at $136.98 on Monday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. The company has a market cap of $5.80 billion, a PE ratio of -5.88, a PEG ratio of 0.91 and a beta of 0.81. Teleflex has a 52-week low of $100.18 and a 52-week high of $145.00. The stock has a 50-day simple moving average of $132.38 and a 200 day simple moving average of $123.81.
Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The firm had revenue of $570.33 million for the quarter, compared to analysts' expectations of $559.59 million. During the same quarter in the previous year, the business posted $3.73 EPS. The business's quarterly revenue was up 28.9% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, sell-side analysts expect that Teleflex will post 7.26 EPS for the current fiscal year.
Teleflex Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be given a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex's payout ratio is currently -5.84%.
Teleflex Company Profile
(
Get Free Report)
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.